Validation of the Center for Epidemiologic Studies Depression Scale (CES-D) in a Moroccan sample with substance use disorder

被引：0
作者：
Abdelfettah El-Ammari
Hicham El Malki
Salma Ghofrane Moutawakkil
Jaouad El Hilaly
Fatima El Houari
Samir El Gnaoui
Mohammed El Amine Ragala
Karima El Rhazi
Btissame Zarrouq
机构：
[1] Sidi Mohamed Ben Abdellah University,Laboratory of Epidemiology and Research in Health Sciences, Faculty of Medicine, Pharmacy, and Dental Medicine
[2] Sidi Mohamed Ben Abdellah University,R.N.E Laboratory, Multidisciplinary Faculty of Taza
[3] Laboratory of Pedagogical and Didactic Engineering of Sciences and Mathematics,Department of Biology
[4] Regional Center of Education and Training (CRMEF) of Fez,Geology, Teachers Training College (Ecole Normale Superieure)
[5] Addictology Center of Fez,undefined
[6] Sidi Mohamed Ben Abdellah University,undefined
来源：
BMC Psychiatry | / 23卷
关键词：
Psychometric quality; Convergent validity; Discriminant validity; Reliability; Composite reliability; Substance use disorder; Depression; Center for Epidemiologic Studies Depression Scale (CES-D);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 329 条
[1]  
Rehm J(2019)Global burden of disease and the impact of mental and addictive disorders Curr Psychiatry Rep 21 1-7
[2]  
Shield KD(2015)Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010 Epidemiol Psychiatr Sci 24 121-140
[3]  
Charlson FJ(2015)Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis JAMA Psychiat 72 334-341
[4]  
Baxter AJ(2020)Mental health matters. Lancet Glob Health 8 e1352-50
[5]  
Dua T(2022)Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet Psychiatry. 9 137-62
[6]  
Degenhardt L(2015)Current status of co-occurring mood and substance use disorders: a new therapeutic target Focus. 13 356-539
[7]  
Whiteford HA(2017)A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia Drug Alcohol Rev 36 527-12
[8]  
Vos T(2021)Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Lancet. 398 1700-s284
[9]  
Walker ER(2016)The impact of anxiety and depression on academic performance in undergraduate medical students Eur Psychiatry 33 s284-8
[10]  
McGee RE(2022)Risk of suicide ideation in comorbid substance use disorder and major depression PLOS One 17 e0265287-2186
12345678910